CoChat

Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Abstract

D-Allulose is a rare sugar that exists in nature. It is a food ingredient with nearly zero calories (<0.4 kcal/g) and has many physiological functionalities such as attenuation of postprandial blood glucose levels, attenuation of postprandial fat mass accumulation, and anti-aging property. This study focused on the postprandial blood glucose changes in healthy humans by a systematic review and meta-analysis. They were chosen because of its importance to a prevention from diabetes. The study objective was to examine acute blood glucose concentrations of healthy humans after the meal with and without allulose. The study collected all D-allulose related studies from various databases. A forest plot of the comparison between an allulose intake group and the control group showed both 5g and 10g intake groups have the significantly smaller area under the curve of postprandial blood glucose levels. It means that D-Allulose attenuates postprandial blood glucose concentrations in healthy humans. As the result, D-Allulose is a valuable blood glucose management tool for healthy humans and diabetes patients. Allulose Diet enables reduction of sucrose intake through Sugar Reformulation in the future diet.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0281150

Cites

47 of 48 references verified1 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA 2009 flow diagram. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed.1000097 For more information, visit www.prisma-statement.org.
Fig 1 PRISMA 2009 flow diagram. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed.1000097 For more information, visit www.prisma-statement.org.CC BY · PubMed Central
Fig 2 Data extracted from included studies.
Fig 2 Data extracted from included studies.CC BY · PubMed Central
Fig 3 Risk of bias summary for each included study.
Fig 3 Risk of bias summary for each included study.CC BY · PubMed Central
Fig 4 Risk of bias graph for each included study.
Fig 4 Risk of bias graph for each included study.CC BY · PubMed Central
Fig 5 Preliminary funnel plot of incremental AUC at the selected studies for Normal-Intakes "<10g" and control.
Fig 5 Preliminary funnel plot of incremental AUC at the selected studies for Normal-Intakes "<10g" and control.CC BY · PubMed Central
Fig 6 Preliminary funnel plot of incremental AUC at the selected studies for "<5g" Low-Intakes and control.
Fig 6 Preliminary funnel plot of incremental AUC at the selected studies for "<5g" Low-Intakes and control.CC BY · PubMed Central
Fig 7 Forest plot of Random Effect Model for incremental AUC with a comparison between "Normal-Intakes (< = 10g) and control".
Fig 7 Forest plot of Random Effect Model for incremental AUC with a comparison between "Normal-Intakes (< = 10g) and control".CC BY · PubMed Central
Fig 8 Forest plot of Random Effect Model for incremental AUC with a comparison between "Normal-Intakes (< = 5g) and control".
Fig 8 Forest plot of Random Effect Model for incremental AUC with a comparison between "Normal-Intakes (< = 5g) and control".CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 48 references

Research works printed but not linked: 6

  1. Iida T, Okuma K. Physiological Functions of Two Rare Sugars, D-Psicose and D-Allose. J. Jpn. Assoc. Dietary Fiber Res. 2012; 16(1):9-17.
  2. Yamaguchi Y, Kitagawa M, Iida T, Kishimoto Y, Kashiwagi S, Sugino T, et al. Effects of a single intake of psicose(allulose)on fat oxidation during exercise-a randomized, double-blind, placebo-controlled, cross-over trial. Japanese Pharmacology and Therapeutics. 2019; 47(3):517-525.
  3. Matsuo T. Effects of daily intake of the rare sugar D-psicose on liver and muscle glycogen repletion with D-fructose administration after exhaustive swimming. Biotechnol Ind J. 2011; 5(5):290-292.
  4. Matsuo T, Lu C. Cooking Abolishes the Inhibitory Effects of D-Psicose on Glycemic Response. Tech. Bull. Fac. Agr. Kagawa Univ. 2012; 64:31-34.
  5. Matsuo T. Effect of D-Psicose on Glycemic Response after Ingestion of Confectionery Foods in Healthy Subjects. Tech. Bull. Fac. Agr. Kagawa Univ. 2013; 65:33-39.
  6. Livinski A, Joubert D, Terry N. Undertaking a Systematic Review: What You Need to Know. NIH Library Systematic Review Workshop/Handout. 2015. September 29, 2019, https://www.nihlibrary.nih.gov/ sites/default/files/SR_Training_oct2015.pdf.

Cited by

Metadata

Authors
Tani, Y., Tokuda, M., Nishimoto, N., Yokoi, H., & Izumori, K.
Affiliations
  • Matsutani (Japan) (JP)
  • Kagawa University (JP)
  • Hokkaido University Hospital (JP)
  • Kagawa University Hospital (JP)
Corresponding author
  • Tani, Yuma
  • Tokuda, Masaaki
  • Nishimoto, Naoki
  • Yokoi, Hideto
  • Izumori, Ken
Venue
PLOS ONE
Published
2023-04-06
Volume
18
Issue
4
Pages
e0281150
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4362657395
Cited by
31
References
47
Citations by year
2026: 7 · 2025: 10 · 2024: 11 · 2023: 3
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
Keywords
D-allulose, rare sugars, postprandial blood glucose, glycemic control, diabetes prevention, artificial sweeteners, sucrose reduction, healthy humans
MeSH terms
Blood Glucose, Diet, Fructose, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.